The $800 million pill : the truth behind the cost of new drugs /
"Drug companies insist that [prescription drug] prices reflect the millions they invest in research and development ... Merrill Goozner contends that American taxpayers are in fact footing the bill twice: once by supporting government-funded research and again by paying high prices for prescrip...
Saved in:
| Online Access: |
Contributor biographical information Table of contents Publisher description |
|---|---|
| Main Author: | |
| Format: | Book |
| Language: | English |
| Published: |
Berkeley :
University of California Press,
2004
|
| Subjects: |
| Summary: | "Drug companies insist that [prescription drug] prices reflect the millions they invest in research and development ... Merrill Goozner contends that American taxpayers are in fact footing the bill twice: once by supporting government-funded research and again by paying high prices for prescription drugs. Goozner demonstrates that almost all of the important and life-saving new drugs of the past quarter-century actually originated from research at taxpayer-funded universities and the National Institutes of Health ... [Goozner] suggests ways that the government's role in testing new medicines could be expanded to eliminate private-sector waste driving up the cost of existing drugs--p. [2] of jacket. |
|---|---|
| Physical Description: | 297 pages ; 24 cm |
| Bibliography: | Includes bibliographical references (p. 281-283) and index. |
| ISBN: | 0520239458 (hbk. : alk. paper) |
